Debra Schiela, MBA
About Debra Schiela, MBA
Debra Schiela, MBA, serves as the Director of Payer and Market Access for Cell Therapy at Kite Pharma, Inc., where she certifies oncology centers of excellence and leads market access strategy. With extensive experience in oncology and market access, she has successfully launched CAR T therapies and built strong relationships with key stakeholders in the healthcare sector.
Work at Kite Pharma
Debra Schiela has been serving as the Director of Payer and Market Access for Cell Therapy at Kite Pharma, Inc. since 2017. In this role, she is responsible for developing market access strategies and certifying high-profile oncology centers of excellence. Her efforts focus on ensuring payer coverage and access for innovative therapies, particularly in the Mid-Atlantic and Northeast regions. Schiela has played a significant role in the launch and commercialization of CAR T therapies, including Yescarta and Tecartus.
Previous Experience at Genentech
Before her current position, Debra Schiela held multiple roles at Genentech. She worked as a Senior Clinical Oncology Specialist from 2001 to 2003 and later as a Regional General Manager in Managed Markets from 2011 to 2012. Additionally, she served as a Senior National Account Manager/Senior Account Manager from 2003 to 2011. Her tenure at Genentech spanned over a decade, during which she developed expertise in oncology and market access.
Experience at Incyte
Debra Schiela worked at Incyte as a Senior National Account Executive from 2016 to 2017. In this role, she focused on managing national accounts and enhancing market access strategies. Her experience at Incyte contributed to her understanding of the oncology landscape and payer dynamics.
Education and Expertise
Debra Schiela holds a Bachelor of Science degree in Marketing, Management, and Biology from La Salle University. She furthered her education by obtaining a Master of Business Administration (MBA) from the same institution, specializing in Finance and Marketing. Her academic background supports her extensive expertise in market access, reimbursement issues, and stakeholder engagement.
Achievements in Market Access
Throughout her career, Debra Schiela has been acknowledged for her ability to build and maintain positive relationships with key opinion leaders across various segments. Her networking efforts have contributed to successful sales and negotiations, particularly in the oncology field. Schiela has deep expertise in resolving reimbursement issues and facilitating discussions at Kite Authorized Treatment Centers to optimize access for patients and providers.